(Q42723314)

English

VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC.

scientific article published on 29 November 2011

In more languages
default for all languages
No label defined

No description defined

Statements

VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC. (English)
Gregory N Dietsch
Maura-Ann H Matthews
Katherine E Henderson
James Jeffry Howbert
Robert M Hershberg

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit